Skip to main content

stock

FEED · ENvue Medical, Inc.

What ENvue Medical, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live FEED price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on FEED.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
11,084,615 as of 2026-08-17 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
-26.1%
Operating
-1362.7%
Net
-1093.6%

Returns

ROE
-68.5%
ROA
-54.8%

Health

Current ratio
0.7x
Debt/equity
—

Deep value

NCAV
-$2.83M
NCAV per share
-$0.26
Price/NCAV
Locked
NNWC
-$5.12M
NNWC per share
-$0.46
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$239,000-$266,000-$5.47M-$4.90M
10-Q filed 2026-08-17
2026-03-31$653,000-$55,000-$3.71M-$3.82M
10-Q filed 2026-05-18
2025-12-31$312,000-$370,000-$14.81M-$12.85M
10-K filed 2026-04-15
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$722,000$189,000-$2.25M$510,000
10-Q filed 2025-11-14
2025-06-30$494,000-$35,000-$3.98M-$3.97M
10-Q filed 2026-08-17
2025-03-31$1.02M$369,000-$1.85M-$1.87M
10-Q filed 2026-05-18
2024-12-31$444,000$283,000-$1.37M-$1.43M
10-K filed 2026-04-15
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$376,000$133,000-$970,000-$998,000
10-Q filed 2025-11-14
Assets
$38.41M
Equity
$30.76M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$2.55M-$22.89M-$18.18M-$9.43M
2024-12-31$2.56M-$3.58M-$3.71M-$2.52M
2023-12-31$2.28M-$3.44M-$3.71M-$3.60M
2022-12-31$752,000-$5.01M-$5.45M-$7.04M
2021-12-31$1.70M-$5.68M-$14.28M-$4.37M
2020-12-31$623,000-$4.72M-$4.33M-$3.39M
2019-12-31$530,000-$5.15M-$5.79M—
2018-12-31$318,000-$4.30M-$4.15M-$3.56M
2017-12-31$239,000-$3.09M-$4.96M—
2016-12-31$229,000-$2.32M-$2.83M-$1.54M

Company filings

since Mon Aug 10 · 2 offering filings in 12 months

events

  • Bylaws or fiscal year change, Other event

    Bylaws or fiscal year changeOther event
    Aug 318-K
  • Shareholder vote results

    Shareholder vote results
    Aug 148-K
  • Material agreement

    Material agreement
    Aug 128-K
  • Executive or director change

    Executive or director change
    Jul 148-K
  • Listing standard notice

    Listing standard notice
    Jul 108-K
  • Executive or director change

    Executive or director change
    Feb 68-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named FEED, and the market events around them.

Sign in to see this

Board

The FEED board could not be loaded.

Retry the FEED board

nakagai

Signals on FEED come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the FEED board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

ENvue Medical, Inc. (FEED): SEC filings, financials and insider trades · Nakagai